The RMDC understands that pharmaceutical companies' customers will have product questions and can convey important information regarding products' safety profiles at any time and by different means. Thus the RMDC is available 24/7 via telephone, fax or mail.
The RMDC understands that spontaneous reports of adverse events involving pharmaceutical products may need to be forwarded to the Food and Drug Administration (FDA). The RMDC can collect adverse event details and compose reports to meet both the FDA's reporting requirements and internal information needs.
FDA MedWatch Site and Forms
RMDC professionals provide accurate information on the safe and effective use of products. Computerized systems and on-line databases that house package inserts, medical letters, and other product information ensure customers receive accurate medical information.
During consultations, RMDC professional staff sometimes receives secondary information and opinions on the quality of a product. This feedback is valuable information to pharmaceutical companies, and as such the RMDC can capture it and condense it in organized reports.
The RMPDC manages a comprehensive quality assurance program that ensures customers are given the most up to date medial information and that reports are clear and accurate.
|
|
Search
|
|
Our professional staff includes:
§ Clinical Toxicologists,
§ Physicians,
§ Pharmacists,
§ Nurses, and
§ Poison Information Specialists
|
|
Why Choose RMPDC?
§ Competitively priced services.
§ Expertise of our professionals.
§ 24-hour availability providing a consistent safety net.
§ State-of-the-art computer and phone systems ensure regulatory reports are accurate, easy to read an on time.
§ Quality Assurance programs ensure accuracy of information.
|
Why Outsource Your Medical Information Services to RMPDC?
§ Relieves clients of staffing, budget, technology and other concerns associated with internal programs.
§ Assures documented fulfillment of regulatory requirements.
§ Expand the range of value-added services for your customers.
§ Reduced product liability risk
|
|
|